News Daily News High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients Michael O'Riordan January 12, 2016
News Daily News Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases Todd Neale January 06, 2016
News Industry News Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments January 03, 2016
News Industry News FDA approves wearable defibrillator for children at risk for sudden cardiac arrest December 17, 2015
News Daily News Sugary Drinks an Increasing Threat to Global Cardiometabolic Health Todd Neale December 02, 2015
News Daily News Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global Todd Neale December 02, 2015
News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015
News Daily News La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere Todd Neale November 01, 2015
News Daily News Door Closing on Low-fat Diets for Long-term Weight Management Todd Neale November 01, 2015
Presentation Effect of Low-fat vs Other Diet Interventions on Long-term Weight Change in Adults Presenter: Deirdre Tobias October 30, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Daily News RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline September 22, 2015
News Daily News RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar September 22, 2015
News Industry News Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab) September 11, 2015
News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015
News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Industry News Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia July 24, 2015
News Industry News Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet July 23, 2015